Switching from Kaletra to Reyataz decreased belly fat- conflicting info

[Guest guest]

Visceral adipose tissue area decreased significantly in patients who switched to atazanavir/ritonavir compared with those who stayed on lopinavir/ritonavir (-15.5% vs +10.8%; treatment effect -31 cm; P = 0.047).

http://www.hivandhepatitis.com/recent/2009/071009_b.html

Comment:

This is a very tiny study but done by researchers that I respect.

This study contradicts one published previously that found no difference in belly fat when switching.

Here is the older study:

http://www.hivandhepatitis.com/2008icr/AIDS2008/docs/081908_c.html

Finding the best videos just got easier. Try the NEW Truveo.com.